Assistance Publique Hopitaux De Marseille
- Address
- 264 Rue Saint Pierre, 13005 Marseille, France
Periodontology and Oral Infection Research
At Assistance Publique Hopitaux De Marseille, clinical trials in parodontology focus on generalized periodontitis and related infectious disease questions. The studies are designed to assess whether adding a new antiviral approach can improve outcomes alongside standard periodontal care.
- Evaluation of valaciclovir as a potential support to conventional non-surgical periodontal treatment
- Assessment of treatment effectiveness for advanced periodontitis in adults
- Research linking virus diseases and inflammatory conditions of the gums
This work aims to refine care for severe gum disease by comparing new therapeutic strategies with established dental treatment.
Digestive System Disease Studies
The site also conducts trials in digestive system diseases, with a strong emphasis on esophageal achalasia and reflux prevention after treatment. These studies explore ways to improve symptom control and reduce later complications in patients undergoing endoscopic care.
- Prevention of gastroesophageal reflux after treatment for achalasia
- Comparison of routine versus symptom-guided PPI use
- Improving long-term digestive outcomes after POEM
The research is centered on testing better follow-up strategies and evaluating how to reduce reflux-related problems after intervention.
Hormonal Disease and Metabolic Care
Clinical research in hormonal diseases includes studies in type 2 diabetes, where investigators are examining whether changing therapy can lead to better blood sugar control. This reflects a practical focus on improving treatment effectiveness for patients already receiving diabetes care.
- Comparison of two GLP-1-based treatments for glycemic control
- Evaluation of treatment switching in adults with type 2 diabetes
- Measurement of changes in HbA1c over time
The goal is to identify more effective options for managing diabetes in everyday clinical practice.
Skin and Connective Tissue Disease Research
Trials in skin and connective tissue diseases at this hospital site intersect with inflammatory and tissue-related conditions that affect the mouth and surrounding structures. The research supports a broader effort to understand how chronic inflammation responds to different treatment approaches.
- Study of inflammatory tissue changes associated with periodontal disease
- Testing strategies that may improve healing in chronic connective tissue conditions
- Clinical evaluation of therapies aimed at reducing persistent inflammation
These studies are intended to strengthen knowledge of how chronic tissue disorders can be managed more effectively.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 35 therapeutic areas and 15 of 945 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 892 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 214 by active trials.
lock +213 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +131 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Assistance Publique Hopitaux De Marseille
lock Showing 1 of 966 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (21492 ARASTEP) A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide plus androgen deprivation therapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) of prostate cancer | Bayer AG, Bayer Consumer Care AG | Phase III | Not Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 945 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 75 | Unknown | 2015-07-16 | 2026-05-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.